NEFL and myeloid sarcoma: Nevertheless, an interesting observation is that highly effective disease‐modifying therapies (DMTs), in particular B‐cell‐depleting therapies, have been shown to normalize blood NfL levels in both relapsing‐remitting and progressive MS diseases (Bar‐Or et al., 2019).